Your browser is no longer supported. Please, upgrade your browser.
Settings
LGVN [NASD]
Longeveron Inc.
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand19.00M Perf Week-7.92%
Market Cap70.43M Forward P/E- EPS next Y- Insider Trans- Shs Float2.60M Perf Month-7.18%
Income- PEG- EPS next Q- Inst Own10.90% Short Float9.91% Perf Quarter-39.62%
Sales4.30M P/S16.39 EPS this Y-25.70% Inst Trans0.32% Short Ratio1.69 Perf Half Y-42.79%
Book/sh1.30 P/B2.68 EPS next Y- ROA- Target Price- Perf Year-
Cash/sh1.06 P/C3.29 EPS next 5Y- ROE- 52W Range3.20 - 12.48 Perf YTD-52.90%
Dividend- P/FCF- EPS past 5Y- ROI-151.10% 52W High-72.60% Beta-
Dividend %- Quick Ratio10.10 Sales past 5Y- Gross Margin- 52W Low6.88% ATR0.25
Employees12 Current Ratio10.10 Sales Q/Q-72.20% Oper. Margin- RSI (14)42.59 Volatility7.28% 7.36%
OptionableNo Debt/Eq0.00 EPS Q/Q-941.10% Profit Margin- Rel Volume0.25 Prev Close3.49
ShortableYes LT Debt/Eq0.00 EarningsAug 13 BMO Payout- Avg Volume152.41K Price3.42
Recom- SMA20-4.74% SMA50-5.19% SMA200-40.53% Volume23,790 Change-2.01%
Oct-28-21 11:00AM  
Oct-27-21 10:55PM  
10:41PM  
09:00PM  
05:21PM  
03:45PM  
Oct-26-21 03:45PM  
03:35PM  
10:00AM  
Oct-25-21 11:32PM  
02:40PM  
11:00AM  
Oct-23-21 09:15AM  
Oct-22-21 05:06PM  
11:00AM  
Oct-21-21 03:30PM  
11:00AM  
Oct-20-21 07:58PM  
08:30AM  
Oct-19-21 09:00PM  
05:45PM  
01:15PM  
11:00AM  
Oct-18-21 07:48PM  
Oct-17-21 10:00AM  
Oct-16-21 08:59AM  
Oct-15-21 08:53PM  
05:12PM  
Oct-14-21 04:19PM  
02:50PM  
08:00AM  
Oct-13-21 10:00PM  
07:53PM  
05:50PM  
04:10PM  
09:52AM  
Oct-12-21 12:15PM  
11:00AM  
Oct-11-21 04:27PM  
Oct-09-21 04:38PM  
11:00AM  
Oct-08-21 03:15PM  
Oct-07-21 10:00PM  
07:00PM  
04:30PM  
Oct-06-21 08:38PM  
04:55PM  
12:30PM  
Oct-05-21 05:50PM  
12:30PM  
11:00AM  
Oct-04-21 02:21PM  
10:00AM  
08:43AM  
Oct-03-21 06:41PM  
Oct-02-21 08:00AM  
Oct-01-21 04:34PM  
02:25PM  
10:00AM  
Sep-30-21 11:00AM  
Sep-29-21 09:03PM  
07:45PM  
01:35PM  
10:00AM  
09:40AM  
Sep-28-21 03:30PM  
01:15PM  
08:00AM  
Sep-27-21 09:22PM  
08:40PM  
04:40PM  
03:18PM  
01:15PM  
11:00AM  
Sep-25-21 03:04PM  
Sep-24-21 11:00AM  
09:30AM  
Sep-23-21 03:19PM  
12:15PM  
10:00AM  
Sep-22-21 09:02PM  
01:25PM  
Sep-21-21 08:30PM  
04:35PM  
02:55PM  
02:05PM  
08:00AM  
Sep-20-21 04:35PM  
11:00AM  
Sep-19-21 09:10PM  
11:00AM  
Sep-18-21 08:00PM  
Sep-17-21 07:23PM  
03:05PM  
11:05AM  
10:00AM  
Sep-16-21 05:54PM  
05:03PM  
03:00PM  
11:15AM  
Longeveron Inc., a clinical stage biotechnology company, engages in developing cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications comprising aging frailty, alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is headquartered in Miami, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Green GeoffCEOOct 13Buy3.811,0003,810139,723Oct 14 09:00 AM
Soffer RockDirectorOct 13Buy3.7612,00045,12051,757Oct 13 06:00 PM
Hare JoshuaChief Scientific OfficerOct 12Buy3.692,5009,2257,933,263Oct 14 09:00 AM
Soffer RockDirectorOct 12Buy3.574,00014,28039,757Oct 13 06:00 PM
Soffer RockDirectorOct 11Buy3.453,90013,45535,757Oct 13 06:00 PM
Hare JoshuaChief Scientific OfficerOct 08Buy3.393,01510,2217,930,763Oct 12 09:30 AM
Clavijo JamesCFO and TreasurerOct 07Buy3.345,00016,70079,598Oct 12 09:30 AM
Hare JoshuaChief Scientific OfficerOct 07Buy3.381,9856,7097,927,748Oct 12 09:30 AM
Lehr Paul TGeneral Counsel, SecretaryOct 07Buy3.341,7505,845116,366Oct 12 09:30 AM
Soffer Donald MDirectorFeb 12Buy10.00100,0001,000,000153,514Feb 26 06:00 PM
Soffer RockDirectorFeb 12Buy8.0510080526,857Feb 26 06:00 PM